Tracking Daily Impact of Generalized Myasthenia Gravis Using Smartphone-Based Digital Biomarkers: Lessons Learned from a 1-Year Study with ME&MGopen (P9-11.030)
To describe longitudinal real-world adherence, digital biomarkers and satisfaction outcomes collected using the ME&MGopen™ app in patients with generalized myasthenia gravis (gMG).
Authors
- Noura Sellami (ORCID: https://orcid.org/0000-0003-4349-3557)
- Loïc Carment (ORCID: https://orcid.org/0000-0002-1358-2877)
- Clarissa Gorin
- James F. Howard (ORCID: https://orcid.org/0000-0002-7136-8617)
- Carolina Barnett‐Tapia
- Saad Zinaï
- Sophie Lehnerer (ORCID: https://orcid.org/0000-0001-9007-027X)
- Dellini Ravindra
- Bhaskar Dutta (ORCID: https://orcid.org/0000-0002-4352-5419)
Institutions
- University of North Carolina at Chapel Hill (US)
- University Health Network (CA)
- University of Toronto (CA)
- Humboldt-Universität zu Berlin (DE)
- Alexion Pharmaceuticals (United States) (US)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211119
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00